(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CONVERGE CONSULTING

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CONVERGE CONSULTING

ST13

US500000097380030

Class

35, 40

Filing

97380030

Registration

7498186

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

09/10/2024

Trademark type

Word

Nice classes

35, 40

Filing date

04/25/2022

Registration date

09/10/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/10/2024

Last transaction

09/10/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

01/30/2017

First use in commerce

02/13/2017

Drawing code

4

Owner type

16

Owner location

Cambridge, MA

Examiner

COHEN, ROBERT ANDREW

Law office

L30

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Converge Consulting, LLC

Representatives

Sean D. Detweiler MORSE, BARNES-BROWN & PENDLETON, P.C.

Technical classification

Nice Classes

Class 35Class 40

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business consulting services in the field of pharmaceuticals; Business strategy development services in the field of pharmaceuticals; Business operations consulting in the field of pharmaceuticals; Business consultation relating to supply chains in the field of pharmaceuticals

Class 40

Manufacturing process consulting in the field of pharmaceuticals; Manufacturing quality process consulting in the field of pharmaceuticals; Providing technical information in the field of pharmaceutical manufacturing

Publications

History of USPTO decisions and trademark events.

29 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/10/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

09/10/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/25/2024

PUBO

PUBLISHED FOR OPPOSITION

06/25/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/05/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/21/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

05/21/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/21/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

05/21/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/21/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/19/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/19/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/19/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/29/2024

GNRT

NON-FINAL ACTION E-MAILED

01/29/2024

CNRT

NON-FINAL ACTION WRITTEN

01/29/2024

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

12/27/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

04/26/2023

GNSL

LETTER OF SUSPENSION E-MAILED

04/26/2023

CNSL

SUSPENSION LETTER WRITTEN

04/26/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/28/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/27/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/27/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/17/2023

GNRT

NON-FINAL ACTION E-MAILED

02/17/2023

CNRT

NON-FINAL ACTION WRITTEN

02/17/2023

DOCK

ASSIGNED TO EXAMINER

02/10/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/29/2022

NWAP

NEW APPLICATION ENTERED

04/28/2022

Continuous trademark protection

Get notified about every new filing that threatens CONVERGE CONSULTING or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.